Comparison of treprostinil and oral sildenafil for the treatment of persistent pulmonary hypertension of the newborn: a retrospective cohort study

Ductus arteriosus flow predicts outcome in neonates with congenital diaphragmatic hernia

(2023) Bartolomeo Bo et al.   PEDIATRIC PULMONOLOGY

Pulmonary Vasodilator Therapy in Persistent Pulmonary Hypertension of the Newborn

(2022) Megha Sharma et al.   CLINICS IN PERINATOLOGY

Oral versus intravenous sildenafil for pulmonary hypertension in neonates: a randomized trial

(2022) Chinmay Chetan et al.   BMC Pediatrics

Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertension

(2022) Akram Khan et al.   RESPIRATORY MEDICINE

Effectiveness of oral sildenafil for neonates with persistent pulmonary hypertension of newborn (PPHN): a prospective study in a tertiary care hospital

(2021) Amber Kamran et al.   Journal of Maternal-Fetal & Neonatal Medicine

Sildenafil for pulmonary hypertension in neonates: An updated systematic review and meta‐analysis

(2021) Zonglin He et al.   PEDIATRIC PULMONOLOGY

Pathophysiology and Management of Persistent Pulmonary Hypertension of the Newborn

(2021) Yogen Singh et al.   CLINICS IN PERINATOLOGY

Efficacy and Safety of IV Sildenafil in the Treatment of Newborn Infants with, or at Risk of, Persistent Pulmonary Hypertension of the Newborn (PPHN): A Multicenter, Randomized, Placebo-Controlled Trial

(2021) Christine M. Pierce et al.   JOURNAL OF PEDIATRICS

Cost-Utility of Sildenafil for Persistent Pulmonary Hypertension of the Newborn

(2020) Patrick D. Evers et al.   AMERICAN JOURNAL OF PERINATOLOGY

Effects and Tolerability of Treprostinil in Neonates with Persistent Pulmonary Hypertension

(2019) Mariela Jozefkowicz et al.   AMERICAN JOURNAL OF PERINATOLOGY

Treprostinil Improves Persistent Pulmonary Hypertension Associated with Congenital Diaphragmatic Hernia

(2018) Kendall M. Lawrence et al.   JOURNAL OF PEDIATRICS

Continuous intravenous sildenafil as an early treatment in neonates with congenital diaphragmatic hernia

(2018) Florian Kipfmueller et al.   PEDIATRIC PULMONOLOGY

Treprostinil for persistent pulmonary hypertension of the newborn, with early onset sepsis in preterm infant

(2017) Bo Young Park et al.   MEDICINE

A Comprehensive Review of Treprostinil Pharmacokinetics via Four Routes of Administration

(2016) Parag Kumar et al.   CLINICAL PHARMACOKINETICS

Pulmonary Hypertension in Preterm Infants: Prevalence and Association with Bronchopulmonary Dysplasia

(2014) Hussnain Mirza et al.   JOURNAL OF PEDIATRICS

Safety of Epoprostenol and Treprostinil in Children Less than 12 Months of Age

(2014) Chelsey M. McIntyre et al.   Pulmonary Circulation

Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: Treprostinil is a potent DP1 and EP2 agonist

(2012) Brendan J. Whittle et al.   BIOCHEMICAL PHARMACOLOGY

Peroxisome Proliferator–Activated Receptor–β/δ, the Acute Signaling Factor in Prostacyclin-Induced Pulmonary Vasodilation

(2011) Yingji Li et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

The management of neonatal pulmonary hypertension

(2011) Rami Dhillon   Archives of Disease in Childhood-Fetal and Neonatal Edition

Successful treatment of persistent pulmonary hypertension of the newborn with bosentan

(2009) N Nakwan et al.   ACTA PAEDIATRICA

Dose Proportionality of Treprostinil Sodium Administered by Continuous Subcutaneous and Intravenous Infusion

(2007) C. Shane McSwain et al.   JOURNAL OF CLINICAL PHARMACOLOGY